Alnylam Pharmaceuticals, Inc. (ALNY)
332.59
+3.24
(+0.98%)
USD |
NASDAQ |
Feb 24, 16:00
332.80
+0.21
(+0.06%)
After-Hours: 20:00
Alnylam Pharmaceuticals Price : 332.59 for Feb. 24, 2026
Price Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Price Definition
The price of a security measures the cost to purchase 1 share of a security. For a company, price can be multiplied by shares outstanding to find the market capitalization (value of the company).
Price Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Price Benchmarks
| Insmed, Inc. | 158.65 |
| Biogen, Inc. | 195.10 |
| Pfizer Inc. | 27.14 |
| Eli Lilly & Co. | 1042.43 |
| AbbVie, Inc. | 228.57 |
Price Related Metrics
| PE Ratio | 147.35 |
| PS Ratio | 11.95 |
| Price to Book Value | 55.89 |
| Price to Free Cash Flow | 95.40 |
| Earnings Yield | 0.68% |
| Market Cap | 44.11B |
| Operating PE Ratio | 88.51 |
| Normalized PE Ratio | 133.58 |